PFS Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
PFS Partners's MDT Position: Q2 2026 in Review
PFS Partners reduced its Medtronic (MDT) stake by 20% in Q2 2026, selling an estimated $3.06K and leaving 156 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #362.
PFS Partners first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $22.3K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- PFS Partners held 156 shares of Medtronic worth $12.2K as of Q2 2026.
- PFS Partners sold 38 Medtronic shares in Q2 2026, an estimated $3.06K.
- Medtronic made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #362 holding.
- PFS Partners first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
- PFS Partners's Medtronic position peaked at $22.3K in Q4 2025.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.